Is Splenectomy Required for Treating ITP Long Term?

The short answer is no—you do not necessarily need to have your spleen removed to manage Immune Thrombocytopenia (ITP). While splenectomy (the surgical removal of the spleen) was historically a standard, early treatment for ITP, modern medical guidelines have shifted significantly ^[1]. Today, splenectomy is considered just one of several second-line options—alongside targeted medications—after initial treatments like corticosteroids stop working ^[2]. It is important to know that no treatment, including splenectomy, guarantees a permanent “cure.” ITP treatment focuses on maintaining a safe platelet count to prevent bleeding, rather than achieving a perfectly normal platelet count ^[3].

Safety note: If you experience severe or uncontrolled bleeding, black or bloody stools, vomiting blood, sudden severe headaches, or neurological changes, seek urgent emergency medical care. Do not wait for a scheduled appointment to discuss long-term treatment options.

Why Consider Removing the Spleen?

The spleen is a major site in the body where your immune system destroys antibody-coated platelets. Removing it can help keep more platelets in your circulation ^[2]. While a splenectomy can offer a durable, treatment-free remission for some people, it is not guaranteed to work forever, and some patients still need ongoing medication afterward ^[3]. Because of the availability of newer medications, guidelines often favor delaying surgery—sometimes for 12 months or more—to see if medical options can stabilize your condition first ^[1].

Modern Alternatives to Surgery

When initial treatments aren’t enough, your doctor will discuss several individualized options. You do not necessarily have to “fail” every medication before choosing surgery, but medical alternatives are often tried first ^[3].

• TPO-receptor agonists (TPO-RAs): These are medications that stimulate your bone marrow to produce more platelets. Systematic reviews suggest they are often preferred early alternatives to splenectomy for people with persistent or chronic ITP ^[4].
  • Trade-offs: They generally require ongoing daily dosing and regular blood monitoring. They can also carry risks of blood clots and liver issues ^[5][6].
• Rituximab: This is an infused medication that suppresses the immune system’s attack on your platelets ^[1].
  • Trade-offs: Its beneficial effects can be temporary, and it carries risks of infusion reactions, a reduced ability to respond to vaccines, and an increased risk of infections.

Understanding the Risks of Splenectomy

If you and your care team consider surgery, it is vital to weigh the immediate and lifelong risks against the potential benefits:

Immediate Surgical Risks

Like any major operation, splenectomy involves risks from anesthesia, surgical bleeding, and potential injury to nearby organs. There is also a risk of immediate postoperative blood clots, particularly in the veins of your abdomen ^[7].

Lifelong Infection Risk

The spleen plays a crucial role in fighting off certain bacteria. Without it, you face a rare but lifelong risk of overwhelming postsplenectomy infection (OPSI)—a severe, rapidly progressing infection that can occur even decades after the surgery ^[8][9].

• Vaccinations: To reduce this risk, you will need specific vaccines (such as for pneumococcal, meningococcal, and Hib bacteria) ideally completed before an elective surgery ^[10][11].
• Antibiotics: Some patients require daily antibiotic prophylaxis, depending on their age and health status ^[9].
• Emergency Plan: Most importantly, any fever after a splenectomy requires urgent, emergency medical evaluation, as infections can deteriorate rapidly ^[12]. Patients should always carry a medical alert card identifying them as not having a spleen.

Blood Clots and Cardiovascular Risk

Splenectomy is associated with an increased long-term risk of thrombosis, which means developing blood clots in your veins (venous) or arteries (arterial) ^[7][13]. Research has also linked spleen removal to a higher long-term risk of cardiovascular disease ^[14][15]. Because ITP itself and certain medications also affect clotting risks, your doctor must carefully assess your personal risk factors ^[16][17].

How the Decision is Made

Choosing between ongoing medications and surgery is a shared decision. Your doctor will not simply look at your platelet count; they will consider your bleeding symptoms, age, cardiovascular health, infection risk, treatment burden, and your personal lifestyle preferences ^[16][17]. The ultimate goal is to safely manage your bleeding risk while minimizing the side effects and burdens of treatment.